arXiv.itsnick.co

an independent field guide to 23 million papers from arXiv & OpenAlex — not affiliated with arXiv.org

Author

C. Haglund

2 papers · 2002–2016

2002: 12003: 02004: 02005: 02006: 02007: 02008: 02009: 02010: 02011: 02012: 02013: 02014: 02015: 02016: 1
2002peak 1 in 20022016

Frequent co-authors

Papers

showing 1–2 of 2 RSS

Modelization of hybrid systems by combination of Petri nets representation an a bond-graph with variable causality

Théodore Bloch, Jean‐François Aubry, C. Haglund +1 more

Computational Theory and Mathematics · · cited 1× · DOI ↗ · more like this ·

This paper presents a complete way of creating event-continuous models for hybrid systems. The development of the event model is formalised as well as the results, the latter being done using Petri nets. The continuous model is constructed using bond graphs with variable causality, including a suitable representation of the switch elements.< <ETX xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">&gt;</ETX>

Preoperative serum levels of CEA and CA 242 in colorectal cancer

M Carpelan-holmstrm, C Haglund, P Kuusela +1 more

Political Science and International Relations · · cited 0× · OpenAlex ↗ · more like this ·

cancer and in 92 patients with benign colorectal diseases. The overall sensitivity of the CEA test was 43 % and of the CA 242 test 39%. The corresponding specificities were 90 % and 87 % respectively, using 5 ng ml- &amp;apos; as cut-off level for CEA and 20 U ml- &amp;apos; for CA 242. The sensitivity of CEA was 26%, 32%, 38 % and 77 % for Dukes A, B, C and D colorectal cancer, and the sensitivity of CA 242 was 26%, 26%, 40 % and 67%, respectively. The correlation between CEA and CA 242 was low. Concomitant elevation of both markers was seen in 5%, 12%, 18 % and 59 % of patients with Dukes A, B, C and D colorectal cancer, respectively. Of all the patients, 23 % showed elevation of both the CEA and the CA 242 level, whereas CEA alone was elevated in 20 % and CA 242 alone in 15 % of the patients with colorectal cancer. Combined use of both markers raised the overall sensitivity from 43 %…